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ABSTRACT 
Kinetic studies of the cleavage of dehydroepian- 
drosterone-sulfate (i) and androstenediol-3-sulfate by 
a particulate enzyme preparation from a rat testicular 
microsomal fraction gave K m values of 2.04 x 10-6M for 
DHA-S and 0.935 x 10-6M for androstenediol-3-sulfate 
with identical Vma x values° Inhibition studies with 
equimolar concentrations of substrate and inhibitor 
demonstrated that 5~-androstane-3~,17~-diol was the 
most potent inhibitor among fifteen C-19 and C-18 
unconjugated steroids investigated. Substitution of: 
i) a A 4 or A5 bond or phenolic A ring for a saturated A 
ring, 2) 17~-hydroxyl group for a 17~-hydroxyl group, or 
3) a 3~-hydroxyl group for a 3~-hydroxyl group, markedly 
decreased the inhibitory effect of the steroid. K i 
values of 1.7 x 10-6M, 3.3 x 10-6M and 11.8 x 10-6M were 
found with 5~-androstane-3~,17~-diol, 5~-androstane-3~, 
17~-diol and testosterone, respectively. The kinetic 
data related to inhibition are consistent with partial 
competitive inhibition. 
In previous studies of the comparative gonadal 
metabolism of dehydroepiandrosterone (DHA) and 
dehydroepiandrosterone-sulfate (DHA-S) it was found 
that a soluble extract of rat testes converted DHA-S to 
androstenediol-3-sulfate (A5-diol-3-S) four times as 
fast as DHA to androstenediol (2). In similar 
experiments (3) in which 3H-DHA-S and 14C-DHA were 
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incubated with a microsomal preparation of rabbit 
ovaries, DHA-S was converted to A5-diol-3-S and the 
following free steroids: testosterone, androstenedione, 
5~-androstane-3~,17~-diol (3~-A-dio!), dihydrotestosterone 
and epiandrosterone. To elucidate further the role of 
A5-diol-3-S in the biosynthesis of gonadal androgens, 
the cleavage of DHA-S and A5-diol-3-S by a particulate 
fraction from rat testes was compared. 
The recent report by Notation and Ungar (4) that 
DHA-S cleavage occurring in a rat testicular homogenate 
was inhibited by free DHA and testosterone led us to 
examine the degree and type of inhibition of these and 
other free steroids, especially the 5~-reduced C-19 
steroids which have been demonstrated to be products 
of the DHA-S and DHA metabolic pathway (3,5). 
Experimental 
Materials: The ammonium salt of DHA-7~-3H-S 
(10.4 c/mmole) was purchased from New England Nuclear 
Corporation. It was purified by column partition 
chromatography on Celite in System AIT-I as described 
by Calvin et al. (6). A5-diol-3H-3-S was prepared from 
DHA-7~-3H-S by reduction with potassium borohydride in 
95% methanol, followed by purification on ITLC as 
described previously (7). Radiochemical purity of both 
compounds was established by recrystallization of aliquots 
to constant specific activity (SA). 
DHA-S and ~5-diol-3-S were prepared as the potassium 
salts as described previously (2). DHA, estrone, 
17~-estradiol and estriol were purchased from Sigma 
Chemical Co., epitestosterone from Steraloids, Inc., 
ll~-hydroxyestradiol (U-6814) was a gift from 
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Dr. John Babcock, Upjohn Co. All other steroids were 
obtained from Mann Research Laboratories, Inc. 
Tissue Preparations: Testes were obtained from 
mature Holtzman rats. The testes were decapsulated 
and homogenized in 4 volumes of 0.25 M sucrose in a 
teflon-glass Potter-Elvehjem homogenizer. The homo- 
genate was centrifuged at 15,000 g for 20 minutes. 
The supernatant fluid was centrifuged at 105,000 g 
for 1 hr. The resulting supernate was discarded and 
the pellets were combined in ice-cold water, homo- 
genized briefly and lyophilized. The lyophilized 
preparation was homogenized again (unless otherwise 
indicated) in 0.25 M sucrose and centrifuged for 
90 min. at 105,000 g. The pellets were combined in 
ice-cold water, homogenized and stored in l-ml aliquots 
at -20°C. The protein concentration was approximately 
5 mg/ml. This solution was diluted with water prior 
to incubation. No loss of sulfatase activity was 
observed over 2.5 months. 
Enzyme Assay: The substrate was dissolved in 1 ml 
buffer solution and warmed to 37 ° , the incubation 
temperature. For inhibition studies the substrate 
and free steroid were dissolved in 0.05 ml absolute 
methanol prior to the addition of 0.95 ml buffer 
solution. One ml of diluted enzyme preparation (0.43 - 
0.46 mg/ml) was added and the mixtures were incubated 
for a period of 20 minutes unless otherwise indicated. 
A 0.5 ml aliquot was removed at the appropriate time, 
and delivered into a culture tube and sulfatase 
activity immediately assessed as described by Burstein 
and Dorfman (8). Enzyme activity (v) is expressed as 
~moles of free steroid released per minute per mg 
protein. Controls lacking enzyme were processed simul- 
taneously with the experimental samples. The minute 
amount of radioactivity found in the toluene extract 
from these controls was subtracted from that Of the 
experimental samples. Protein was determined by the 
method of Lowry et al (9). 
Results 
pH Optimum: To determine optimal conditions for 
carrying out the kinetic studies, pH optima were 
determined for rat testis sulfatase activity using 
both DHA-S and A5-diol-3-S as substrates. As seen 
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in Fig. i, the optimum with A5-diol-3-S is between pH 
6.4 and 6.5, while the optimum with DHA-S is at pH 
6.2. Tris-HCl buffer (0.05M) was used for pH levels 
between 7.0 and 8.0 and imidazole -HCl buffer (0.05M) 
between 5.8 and 7.0. Tris-HCl buffer was used at some 
pH levels below 7.0 and no difference in enzyme activity 
was observed between the two buffers at the same pH. 
,'? 
o_ 
i i i ..... I 58 62  66 7 0 7.4 78
pH 
Fig. i. Effect of pH on the 
rate of DHA-S (&) and A 5- 
diol-3-S (e) cleavage. Each 
reaction mixture contained 
1.68 mg lyophilized microsomal 
protein and 4.8 x 10-6M sub- 
strate. The buffers were 0.05M 
Imidazole-HCl at pH values up 
to 6.8 and 0.05M Tris-HCl from 
7°0 to 7.9. v = ~mole/min/mg 
protein. 
The pH optimum observed in the present study was 
considerably lower than previously reported by Burstein 
and Dorfman (8). It seemed possible that lyophilization 
had solubilized the enzyme and that this accounted for 
the observed difference. Thirty-five mg of lyophilized 
microsomal fraction was homogenized in 6.5 ml of 0.25 M 
sucrose and centrifuged for 90 min. at 105,000 g. Over 
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90 per cent of the enzyme activity was recovered in the 
pellet. Although this treatment did not yield a 
solubilized enzyme, it did increase the specific activity 
of the particulate preparation by approximately two-fold. 
Therefore, all subsequent kinetic studies were carried 
out using the recentrifuged lyophilized enzyme 
preparation. 
Enzyme Activity: Fig. 2 shows the variation in 
enzyme activity during a 60 minute incubation. Linearity 
was observed up to 20 min. after which there was some 
deviation from linearity. The concentration of sub- 
strate (3.62 x 10-7M) was the minimum concentration used 
in any of the experiments reported in this study. At 
higher substrate concentrations linearity was observed 
up to 60 min. It should be noted that the line passes 
through the origin and therefore incubation periods up 
to 20 min. reflect initial velocity. The relationship 
between amount of enzyme and reaction velocity is 
illustrated in Fig. 3. A linear relationship between 
velocity and mg protein was observed between 0.24 and 
2.6 mg. All subsequent assays were carried out with 
approximately 0.45 mg of protein. 
Substrate Specificity and Inhibition: Enzyme 
activity was measured at various substrate concentrations 
utilizing DHA-S and AS-diol-3-S in 0.1M imidazole-HCl 
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Fig. 2. (Above) Incubation 
time vs cleavage of DHA-S 
at low substrate concen- 
tration. DHA-S (3.62 x 
10-7M) was incubated with 
the enzyme preparation at 
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Fig. 3. (Right) Enzyme concentration vs cleavage of 
~5-diol-3-S. A5-diol-3-S (1.13 x 10-5M) was incubated 
with indicated amounts of the enzyme preparation. 
Velocity = ~mole/min. 
buffer at pH 6.5. As illustrated in Fig. 4, both 
substrates appeared to be cleaved by the same enzyme 
since they yielded an identical Vma x. However, the 
apparent K m of 0.935 x 10-6M calculated for ~5-diol-3-S 
is considerably lower than the K m of 2.04 x 10-6M for 
DHA-S. Substrate inhibition at high substrate 
concentration (9 x 10-5M) was observed with both 
substrates. When the same experiment was carried out in 
0.1M Tris-HCl buffer at pH 7.4 the apparent K m values for 
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Fig. 4. Relation 
of enzyme activity 
to concentration of 
substrate at pH 6.5. 
Lineweaver-Burk 
plots with DHA-S 
as substrate,~-----~, 
and with A5-diol - 
3-S as substrate, 
O------O. 
A5-diol-3-S and DHA-S were 2.63 x 10-6M and 6.67 x 10-6M 
respectively. Again the Vma x was the same for both 
substrates, but the substrate inhibition was not observed. 
Various C-19 and C-18 free steroids were tested 
for their effect on sulfatase activity. The particular 
steroids were chosen either because they are immediate 
or distant products of metabolism of the substrate, or 
because their substitution and configuration at C-17 
allowed some evaluation of specificity, Table I 
presents the percent inhibition observed when DHA-S or 
A5-diol-3-S was incubated in the presence of equimolar 
concentration of each steroid. Inhibition was deter- 
mined at pH 7.4 and at pH 6.5. 
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The greatest inhibition by all steroids studied 
was observed at pH 7.4 with DHA-S serving as the sub- 
strate. At both pH levels and with both substrates, 
the degree of inhibition depended on the group at C-3 and 
C-17 and the saturation of ring A. In all cases, the 
"diols" inhibited the sulfatase activity to the greatest 
degree. Of the "diols", 3~-A-diol was the most potent 
inhibitor. Substituting a 3~-hydroxyl for a 3~- 
hydroxyl decreased the percent inhibition (i.e. 
compare 2 with 3 and 9 with i0, Table I). Also, sub- 
stituting a A 5, a 4 or a phenolic ring A for a saturated 
ring A decreased the percent inhibition (i.e. 4 vs 5 
with DHA-S as substrate and 1 or 12 vs 3, Table I). 
The same pattern was observed with substitution of a 
17~-hydroxyl for a 17~-hydroxyl as seen by comparing 
the inhibition caused by epitestosterone vs testos- 
terone (4 vs 6, Table I) and 17~-estradiol vs 17~- 
estradiol (12 vs 13, Table I). Addition of a 16~- 
hydroxyl, i.e. estriol, or an ll~-hydroxyl group to 
17~-estradiol obviates the inhibition demonstrated with 
17~-estradiol (14 and 15 vs 12, Table I). A4-andros - 
tenedione which has neither a 3 nor a 17-hydroxyl group 
caused essentially no inhibition (7, Table I). 
To determine the type of inhibition effected by the 
free steroids, varying concentrations of DHA-S were 
14:6 
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Table I. Inhibition of rat testicular steroid sulfatase 
by free steroids* 
Percent Inhibition 
pH 7.4 pH 6.5 
Steroid A5-diol-3-S DHA-S A5-diol-3-S DHA-S 
i. Androstenediol 30 47 14 25 
2. 5~-androstane- 
3~,17~-dioi 31 50 17 27 
3. 5~-androstane- 
3~,17~-dioi 42 71 31 53 
4. Testosterone i0 28 7 13 
5. Dihydrotestosterone -- 42 8 20 
6. Epitestosterone 1 13 1 2 
7. Androstenedione None i0 None 7 
8. Dehydroepiandros- 
terone i0 19 5 ii 
9. Epiandrosterone 15 30 8 16 
i0. Androsterone 7 -- None 4 
ii. Estrone 7 22 12 -- 
12. 17~-Estradiol 28 49 15 23 
13. 17~-Estradiol 8 22 7 ii 
14. Estriol 3 7 4 3 
15. ll~-hydroxy- 
estradiol -- 5 4 3 
Two or more incubations were carried out in 0.1M Tris- 
HCl buffer, pH 7.4, or in 0.1M Imidazole-HCl buffer, 
pH 6.5 with the appropriate substrate at 4.52 x 
10-6M and the appropriate free steroid at 4.34 x 10-6M. 
The values presented are averages. 
incubated in the presence of several levels of 5~- 
androstene-3~,17~-diol (3~-A-diol). Plots of i/v 
against I/S are shown in Fig. 5. The lines intersect the 
ordinate at the same point (Vmax) indicating competitive 
inhibition. Similar results were obtained when varying 
concentrations of ~5-diol-3-S were incubated with several 
levels of testosterone and when varying concentrations 
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Fig. 5. (Left) Inhibition of DHA-S cleavage by 5~-andros- 
t a n e - 3 c ~ , 1 7 ~ 3 - d i o l .  I n c u b a t i o n  c a r r i e d  o u t  f o r  15 m i n .  a t  
pH 6.5. Inhibitor concentration: none,e----e; 6.94 x 
10-6M,D D ; 13.9 x 10-6M, X X ; 27.8 x 10-6M, O O; 
41.7 x 10-6M~ A. 
Fig. 6. (Right) Replot of data from Fig. 5. Substrate 
concentration: 3.65 x 10-7M, e------e; 5.91 x 10-7M,D £3; 
10.4 x 10-TM,~ ~; 23.1 x 10-7M,~ X. 
of DHA-S were incubated with several levels of 3~-A-diol. 
This indicates that these two steroids also act as 
competitive inhibitors. Fig. 6 (i/v vs inhibitor 
concentration at various substrate concentrations) is a 
replot of the data presented in Fig. 5. The resulting 
hyperbolic curves are consistent with partial competitive 
inhibition (i0). The data in Fig. 7 and 8 are plotted 
in the same manner as in Fig. 6. As can be noted, 
testosterone concentration plotted against i/v at a given 
concentration of DHA-S (3.62 x 10-7M also yields a 
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F i g .  7 .  I n h i b i t i o n  o f  DHA-S c l e a v a g e  b y  t e s t o s t e r o n e .  
DHA-S ( 3 . 6 5  x 10-7M) i n c u b a t e d  w i t h  v a r i o u s  a m o u n t s  o f  
t e s t o s t e r o n e  f o r  15 m i n .  a t  pH 6 . 5 .  
hyperbolic curve (Fig. 7). When 3~-A-diol is used as 
the inhibitor, there appear to be two distinct slopes 
instead of a hyperbolic curve (Fig.8). A very abrupt 
change in slope occurs at inhibitor concentrations 
between 5.21 x 10-6M and 6.95 x 10-6M. With inhibitor 
concentrations of 6.95 x 10-6M to 2.78 x 10-5M there 
is a second much more gradual slope. The enzyme activity 
in the presence of 6.95 x 10-6M of 3~-A-diol is greater 
than at the lower inhibition concentration of 5.21 x 
10-6M. The experiment was repeated 5 times with similar 
results. 
Determination of K i values (i0) from the data 
presented in Fig. 5 - 8 were: 3~-A-diol, 1.7 x 10-6M; 
3~-A-diol, 3.3 x 10-6M; and testosterone, 11.8 x 10-6M. 
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Fig. 8. Inhibition 
of DHA-S cleavage 
by 5~-androstane- 
3~,17~-dioi. DHA- 
S (3.65 x 10-7M), 
e----e : DHA-S 
(5.91 x 10-7M), 
A-----~; incubated 
with various 
amounts of 5~- 
androstane-3~, 
17~-diol for 15 
mln. at pH 6.5. 
Discussion 
The cleavage of DHA-S by a microsomal extract or 
homogenates of rat testis has been reported by Burstein 
and Dorfman (8) and Notation and Ungar (4,11). The 
present study was carried out with a particulate prep- 
aration obtained by recentrifuging a lyophilized 
microsomal fraction. This procedure doubled the 
specific enzyme activity of the lyophilized preparation. 
The kinetic studies indicate K m values for DHA-S 
cleavage that are considerably lower than those 
previously reported (8, ii). They also show ~5-diol- 
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3-S is a better substrate than DHA-S and therefore may 
be an important intermediate in the formation of free 
steroids from DHA-S. In an earlier study (2) a soluble 
extract of rat testis was observed to convert DHA-S 
to A5-diol-3-S four times as fast as free DHA was 
converted to androstenediol under identical incubation 
conditions. The microsomal fraction from rat testis, 
in the presence of appropriate cofactors, converted 
DHA-S to A5-diol-3-S, testosterone, and other free 
metabolites (12). Similar results have been obtained 
when incubating DHA and DHA-S simultaneously with either 
a sol.uble or microsomal fraction obtained from rabbit 
/ 
ovaries (3). Perez e_~t a_~l (13) when studying the syn- 
thesis of testosterone from DHA and DHA-S in homogenates 
of testis obtained from a patient with the testicular 
feminization syndrome, isolated both androstenediol 
and ~5-diol-3-S as intermediates. Slaunwhite and 
Burgett (14) have reported the rapid conversion of 
androstenediol to testosterone in rat testicular homo- 
genates. The conversion of DHA-S to testosterone has 
been reported by Aakvaak et al (15) to occur in perfused 
canine testis and ovaries. These investigators were 
unable to detect any free DHA in the spermatic vein 
after infusion of DHA-S into the spermatic artery, 
suggesting that DHA-S may have been reduced to ~5-diol- 
697 
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3-S prior to the cleavage of the sulfate ester. The 
finding in the present study that the K m for ~5-diol- 
3-S is less than half the K m for DHA-S provides support 
for the view that A5-diol-3-S may be an important inter- 
mediate in the conversion of DHA-S to testosterone in 
testis and possibly in other tissues. 
The apparent K m of 2.04 x 10-6M observed in this 
study for DHA-S cleavage is considerably lower than the 
K m for DHA-S cleavage by rat testicular microsomal 
fractions or homogenates reported by Burstein and 
Dorfman (8) and Notation and Ungar (ii). The former 
authors studied DHA-S cleavage in 0.1M Tris-acetate 
buffer, pH 7.2, and reported apparent K m values 
ranging from 0.85 to 2.5 x 10-5M. In the studies of 
Notation and Ungar, DHA-S cleavage was carried out in 
0.1M bicarbonate buffer, pH 7.4, in the presence of ATP, 
~-DPN and K2S04. They reported a K m value for DHA-S 
cleavage of 1 x 10-5M. As shown in the present study, 
the pH optimum for DHA-S cleavage with a lyophilized 
rat testicular microsomal fraction was approximately 
6.2 and that for A5-diol-3-S was approximately 6.5. 
At pH 7.2 or 7.4 the activity of the enzyme changes 
sharply with variation in pH (Fig. i) and this variation 
may complicate the measurement of K values. In the 
m 
present study K m values measured in 0.1M Tris-HCl 
14:6 
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buffer at pH 7.4 were 6.7 x 10-6M for DHA-S and 2.6 x 
10-6M for A5-diol-3-S. The value for DHA-S cleavage 
at pH 7.4 is closer to, but still lower than, previously 
published values. This variation could be due to the 
somewhat purer enzyme preparation used in this study. 
Some variation with different enzyme preparations was 
observed similar to that reported by Burstein and 
Dorfman (8). Preliminary studies suggest that there 
may be a relationship between K m and the age of the rats, 
the higher values being observed in testes obtained from 
older rats. However, further studies need to be done to 
establish this relationship. In all instances the 
relative difference for DHA-S and ~5-diol-3-S cleavage 
was observed. 
Of the various free steroids tested as inhibitor 
of the cleavage of DHA-S or ~5-diol-3-S, 3~-A-diol was 
the most potent when added at levels equimolar to that 
of the substrate (Table i). Three other steroids 
exhibited a lesser but significant capacity to inhibit 
the reaction. These were 3~-A-diol, androstenediol and 
17~-estradiol. DHA and testosterone were much less 
effective as inhibitors while A4-androstenedione was 
practically without effect. 
Notation and Ungar (ii) recently reported 
inhibition of DHA-S cleavage by several of the free 
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steroids that were examined in the present study. When 
a ratio of inhibitor to substrate concentration of 13 
to 1 was employed, the magnitude of inhibition was the 
same or less than that presently reported for equimolar 
concentrations of inhibitor and substrate. Cofactors 
used in the incubation medium by Notation and Ungar 
may have affected the degree of inhibition observed. 
They noted that DHA in the presence of DPN was rapidly 
metabolized; it is likely that androstenediol, estradiol 
and testosterone were also metabolized in the presence 
of this cofactor. Furthermore, ATP, K2SO 4 and Mg ++ 
in their incubation medium could have resulted in 
sulfurylation of 3~-hydroxysteroids as they reported 
previously for DHA (4). 
The demonstratlon in thi~ study that very low 
concentrations of the 5~-A-diols are needed for in- 
hibition of the sulfatase activity, as reflected in 
the low K i values, suggest that either of these 
compounds might control androgen synthesis from DHA-S 
in testis. Gower (5) reported the isolation of 3~-A- 
diol from rat testis incubated with DHA. Over a four 
hour incubation period there was a rapid increase in 
formation of this compound. This "diol" and the 3~- 
A-diol were also identified as products when a rat 
testis homogenate was incubated with testosterone (16). 
14:6 
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The identification of the 3~-A-diol as a product of 
DHA-S and of ~5-diol-3-S metabolism in testes is present- 
ly being investigated. This compound has been identi- 
fied as a product of DHA-S and DHA metabolism by rabbit 
ovary microsomal fraction (3). 
The kinetic data observed for the inhibition of 
DHA-S cleavage by 3~-A-diol suggest that this inhibitor 
acts competitively but at a site distinct from the 
catalytic site. If it was acting competitively at the 
catalytic site one would expect to obtain a linear 
relationship when plotting the reciprocal of the velocity 
against concentration of inhibitor. None of the three 
inhibitors that were more thoroughly investigated gave 
such a linear relationship. The hyperbolic curves 
that result when plotting i/v against concentration 
of 3~-A-diol or testosterone are indicative of allos- 
teric inhibition. The same type of plot for 3~-A-diol 
as the inhibitor did not yield either a continuous 
straight line or a hyperbolic curve. It seems unlikely 
that the kinetics observed with these free steroids are 
a reflection of a decrease in solubility at higher 
inhibitor concentrations since deviation from linearity 
in the i/v vs inhibitor concentration plots occurs at 
J markedly different concentrations of the three in- 
hibitory steroids investigated. 
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At present there is no ready explanation for the 
kinetics observed with the 3~-A-diol as the inhibitor. 
It was recrystallized and checked for purity in three 
separate chromatography systems and yielded a single 
compound in each. It had a melting point of 165 ° which 
agrees well with published melting point (17).. A 
possible explanation for the unusual kinetics is that 
a conformational change of the enzyme occurs at a 
critical concentration of the inhibitor. Enzymes 
exhibiting allosteric effects are usually oligomers 
or polymers involving several interacting subunits. 
A molecular weight of > 600,000 has been reported 
by Burstein (18) for a rat liver microsomal steroid 
sulfatase that cleaves DHA-S. This high molecular 
weight is consistent with the possibility of this 
enzyme existing as a polymer and therefore exhibiting 
the tendency for conformational flexibility. Solubili- 
zation of the testicular enzyme will be required prelimi- 
nary to its rigorous characterization and further studies 
of the mode of inhibition. 
The kinetic data, presented in this report, illus- 
trating inhibition by a distant product (i.e. a 5~-A-diol) 
of the DHA-S androgenic pathway and inhibition by high 
concentrations of substrate are consistent with the 
possibility that this testicular steroid sulfatase may 
Dec. 1969 S T  E R O I D S  703 
act as a "control" enzyme (ii). DHA-S which is present 
in relatively high concentration in plasma (19) and can 
be synthesized within the testis (13, 20) could serve as 
the inactive precursor of active hormones. 
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The following trivial names and abbreviations have 
been used: 
Dehydroepiandrosterone (DHA), 3~-hydroxy-5-androsten- 
17-one; Dehydroepiandrosterone sulfate (DHA-S), 17- 
oxo-5-androsten-3~-yl sulfate; Androstenediol, 5- 
androstene-3~,17~-diol; Androstendiol-3-sulfate 
(A5-diol-3-S), 17~-hydroxy-5-androstene-3~-yl sulfate; 
Androstenedione, 4-Androstene-3,17-dione; Testos- 
terone, 17~-hydroxy-4-androsten-3-one; Dihydrotestos- 
terone, 17~-hydroxy-5~-androstan-3-one; Epitestos- 
terone, 17~-hydroxy-4-androsten-3-one; Epiandrosterone, 
3~-hydroxy-5~-androstan-17-one; Androsterone, 3~- 
hydroxy-5~-Androstan-17-one; 3~-A-diol, 5~-androstane- 
3~,17~-dioi; 3~-A-diol, 5~-androstane-3~,17~-diol; 
Estrone, 3-hydroxy-l,3,5 (10)-Estratriene-17-one; 17~- 
Estradiol, 1,3,5 (10)-Estratriene-3-17~-diol; 17~- 
Estradiol, 1,3,5 (10)-Estratriene-3-17~-diol; Estriol, 
1,3,5 (10)-Estratriene-3,16~,17~-triol; ll~-hydroxy- 
estradiol, 1,3,5 (10)-Estratriene-3,11~,17~-triol. 
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